how many people are on tirzepatide Tirzepatide: Usage and Access Data Real‐world use and effectiveness of

GLP-1 based medicines usually have glucose-dependent effects, but hypoglycemia risk can rise when they are used with insulin or insulin-releasing medicines such as sulfonylureas

Research Evidence on GLP-1s and Vision Loss Risk The primary evidence linking GLP-1 medications to eye complications comes from clinical trials and observational studies examining diabetic retinopathy progression

PLoS One 7, e29968

Accordingly, inventors of the present invention have provided various embodiments showing at least 30 %, at least 50 %, at least 70 % and at least 90 % release over 24 hrs when tested in an In Vitro study using a Franz Diffusion Cell employing a dialysis membrane with l2-l4kd molecular weight cut off